Onur Ozalp

Dr. Onur Ozalp

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2021 in Mikrobiyoloji Bulteni
Verified
Journal Article
Closed access
SKSelda Kömeç
Selda Kömeç
NKNilgün Karabıçak
Nilgün Karabıçak
ACAyşe Nur Ceylan
Ayşe Nur Ceylan
AGAbdurrahman Gülmez
Abdurrahman Gülmez
OOOnur Ozalp
Onur Ozalp
Candida auris is a fungal pathogen that was first identified in 2009. Since its definition, it has spread globally and has caused life-threatening nosocomial infections. Increases in the number of immunocompromised individuals, empirical use of broad-spectrum antimicrobials and widespread use of catheterizations are the predisposing factors in the development of infection. There are problems for the identification of C.auris with the routine methods. In this case report, infections with C.auris, isolated for the first time from three patients in our hospital's intensive care units (ICU) between November 2020-January 2021, were presented. The first case was a 46-year-old male patient with laryngeal carcinoma who developed cardiopulmonary arrest during anesthesia induction in the tumor operation, and was followed up in the ICU. C.auris growth was detected in the blood and intravenous (IV) catheter tip cultures on the 66th day of admittance. Cure achieved on the 24th day under caspofungin treatment as no growth was determined. Second case was a 71-year-old female patient admitted to the emergency department with shortness of breath and general condition disorder that developed after COVID-19 infection and hospitalized in ICU with the diagnosis of pneumonia and acute renal failure. In the 16th day of admittance C.auris growth was detected in blood and from catheter tip cultures and the patient died in the 18th day. The third case was a 49-year-old male patient, followed up in ICU with the diagnosis of subarachnoid hemorrhage after he admitted to the emergency department with confusion. In the 35th day of admittance, 100000 CFU/ mL C auris growth was detected in urine culture. The patient was accepted as asymptomatic fungiuria and followed up in the ICU. It was determined that the three patients were intubated, had urinary and femoral venous catheters and were being followed under wide spectrum antibiotherapy when the growth of C.auris was detected. Isolates identified as C.auris by MALDI-TOF Microflex LT/SH Smart MS in the Medical Microbiology Laboratory were then confirmed by conventional methods and DNA sequencing in the National Mycology Reference Laboratory. Antifungal susceptibility tests were performed by broth microdilution method. Fluconazole MIC values were >256 mg/ml for all cases. Long-term survival in hospital environments, colonization on skin, resistance to disinfectants of C.auris, facilitate the spread of the fungi and resistance to antifungals lead to treatment failures. In this case report, it was aimed to draw attention to the infections with C.auris, its diagnosis and risk factors.

14 April 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
OOOnur Ozalp
Onur Ozalp
EOErkut Ozturk
Erkut Ozturk
Background: Candida infections have become a significant cause of morbidity and mortality in pediatric cardiac intensive care units following congenital heart surgery, ranking among the most common causes of complications in this patient population. There is a paucity of information available regarding the epidemiology, clinical features, and risk factors associated with candidemia in this patient population. The present study evaluates the incidence of Candida bloodstream infections in pediatric cardiac intensive care units. Methods: The study was conducted retrospectively on cases of patients under the age of 18 who were admitted to the pediatric cardiac intensive care unit between 1 January 2021 and 1 January 2024. The isolated pathogens were recorded. A reanalysis was conducted on 36 patients with Candida bloodstream infections, with data pertaining to age, weight, cardiac pathologies, duration of mechanical ventilation, length of hospital stay, and antibiotic use being subjected to further examination. Each case was matched with two control patients based on age and date of surgery. The results were analyzed statistically. Results: A total of 36 cases of candidemia were identified and matched with 72 control cases. The incidence of candidemia was found to be 21.8 episodes per 1000 hospital admissions. The median age of patients with candidemia was four months. Candida species were identified in the blood cultures of 36 out of 1650 patients (0.21%). Candida albicans (n = 12, 33.3%), Candida parapsilosis (n = 16, 44.4%), Candida glabrata (n = 2, 5.5%), and other non-albicans Candida species (n = 6, 16.6%) were isolated. The mortality rate associated with Candida bloodstream infections was 61.1% (22/36). The following independent risk factors were identified as being associated with candidemia: a birth weight of less than 2500 g (OR: 3.2; 95% confidence interval (CI): 2.5–5; p = 0.009), a RACHS-1 score of 4 or above (OR: 2.1; 95% CI: 1.3–6; p = 0.01), cumulative antibiotic exposure of seven days or more (OR: 2.5; 95% CI: 2–10; p < 0.001), duration of central venous catheterization (CVC) of ≥14 days (OR: 6.1; 95% CI: 4–18; p < 0.001), mechanical ventilation dependency of ≥10 days (OR: 4.2; 95% CI: 3–11; p = 0.01), a requirement for total parenteral nutrition (OR: 9; 95% CI: 6–24; p < 0.001), and delayed sternal closure of ≥2 days (OR: 1.8; 95% CI: 1–4; p = 0.04). Conclusions: Postoperative candidemia represents a significant complication in pediatric patients with congenital heart disease (CHD), with different Candida species identified as a potential cause. The primary risk factors that contribute to the likelihood of a Candida bloodstream infection in these cases are a low birth weight, a high RACHS-1 score, dependence on mechanical ventilation, prolonged exposure to antibiotics, prolonged central venous catheter duration, delayed sternal closure, and total parenteral nutrition.

25 May 2026 in BMC Infectious Diseases
Verified
Journal Article
Open access
RKRamazan Korkusuz
Ramazan Korkusuz
SKSelda Kömeç
Selda Kömeç
EÇEsin Çevik
Esin Çevik
AÖAlev Öztaş
Alev Öztaş
ÖAÖzlem Altuntaş Aydın
Özlem Altuntaş Aydın
GAGulcin Hilal Alay
Gulcin Hilal Alay
Candida auris has emerged as a significant global health threat due to its resistance to multiple antifungal agents and its prominent role in healthcare-associated infections. This study aims to compare the clinical characteristics, risk factors, antifungal resistance profiles, and mortality rates of candidemia caused by C. auris and non-auris Candida spp. (NACS). This retrospective cohort study was conducted at a tertiary care hospital from 2021 to 2024. Patients aged 18 years and older with positive blood cultures for Candida spp. were included. Demographic data, comorbidities, risk factors, mortality rates, and treatment protocols were analyzed. A total of 1,088 candidemia cases were included in the study (C. auris: 126 cases, NACS: 962 cases). The length of hospital stay was significantly longer in the C. auris group compared to the NACS group (50.98 ± 38.79 vs. 33.05 ± 25.57 days, p < 0.001). Independent risk factors for C. auris candidemia included longer hospitalization before candidemia (OR 1.01, 95% CI 1.01-1.02, p < 0.001), chronic obstructive pulmonary disease (OR 1.89, 95% CI 1.07-3.31, p = 0.026), prior antifungal use within 30 days (OR 1.92, 95% CI 1.22-3.03, p = 0.005), and ICU admission (OR 2.08, 95% CI 1.10-3.92, p = 0.023). Antifungal resistance rates among C. auris isolates were 96.49% for fluconazole, 72.81% for amphotericin B, and 25.89% for caspofungin. The 30-day mortality rate was lower in the C. auris group (48.4%) compared to the NACS group (60.2%) (p = 0.012). Although crude 30-day mortality was lower in the C. auris group, adjusted analysis showed comparable 30-day mortality between the C. auris and NACS groups. These findings highlight the increasing clinical burden of C. auris and support accurate species identification, local antifungal susceptibility surveillance, and rigorous infection-control measures. Not applicable.

16 July 2018 in Turkish Journal of Intensive Care
Verified
Journal Article
Open access
HŞHelin Şahintürk
Helin Şahintürk
AÖAycan Özdemirkan
Aycan Özdemirkan
FKFatma Kılıç
Fatma Kılıç
OOOnur Ozalp
Onur Ozalp
HAHande Arslan
Hande Arslan
APArash Pirat
Arash Pirat
Amaç: Bu çalışmanın amacı cerrahi hasta kohortunda yoğun bakım kaynaklı çoklu ilaç dirençli ‘extensively drug resistant’ (XDR) bakteriyel enfeksiyonların sonuçlarının değerlendirilmesidir. Gereç ve Yöntem: Başkent Üniversitesi Hastanesi, Anesteziyoloji ve Cerrahi Yoğun Bakım Ünitesi’nde Ocak 2016-Aralık 2016 tarihleri arasında XDR bakteri izole edilen hastaların verileri retrospektif olarak incelendi. İlk 24 saat içinde cerrahi geçirmiş ve yoğun bakım kabulünden 48 saat sonra yoğun bakım kaynaklı enfeksiyon gelişen, 18 yaş üzeri erişkin hastalar çalışmaya dahil edildi. Bulgular: Çalışma süresince cerrahi yoğun bakım ünitesine kabul edilen 341 hastanın hepsi ilk 24 saat içinde cerrahi geçirmiş hastalar idi. Bu 341 hastanın 30’unda (%9) XDR bakteri izole edildi. Ortalama APACHE II skoru 18,5±5,3, ortalama beklenen mortalite hızı 35±17,1 olarak hesaplandı. Ortalama yoğun bakım yatış süresi 27,0±27,4 gün iken ortalama hastane yatış süresi 49,0±34,3 gün idi. Hastane içi mortalite hızının %57 (n=17) olduğu görüldü. Sonuç: Çalışmamızın sonucunda cerrahi yoğun bakım hastalarında XDR bakteriyel enfeksiyonlarının sık görüldüğünü (%9) ve mortalite oranlarının yoğun bakım kabulünde hesaplanan APACHE II skoru ile elde edilen beklenen mortalite oranlarına göre daha yüksek olduğu tespit edilmiştir (%57 vs. %35).

1 January 2025 in Journal of Clinical and Analytical Medicine
Verified
Journal Article
Closed access
OOOnur Ozalp
Onur Ozalp
YYYusuf Yigit
Yusuf Yigit
BÖBeyza Öncel
Beyza Öncel
RKRamazan Korkusuz
Ramazan Korkusuz

4 October 2024 in Medicine
Verified
Journal Article
Open access
SOSerife Ozalp
Serife Ozalp
OOOnur Ozalp
Onur Ozalp
FOFunda Gumuş Ozcan
Funda Gumuş Ozcan
In the low-weight newborn patient group, the development of catheter related bloodstream infections after cardiac surgery significantly impacts morbidity and mortality. In our study, the effects of choosing femoral or internal jugular vein localization in newborns on postoperative infection will be examined. Our hypothesis is that there may be a higher risk of catheter related bloodstream infections in the femoral region. This study was conducted retrospectively on newborn cases who underwent congenital heart surgery between September 1, 2020, and March 1, 2022. The cases were divided into 2 groups: those with central catheters inserted in the femoral and in internal jugular veins. Postoperative infection parameters were examined and the results were statistically evaluated. The study was conducted with a total of 201 newborn cases, of which 61.2% (n = 123) were male and 38.8% (n = 78) were female. The age of the cases ranged from 0 to 1 month, with a mean of 12 ± 9 days. Weight measurements ranged from 1.8 to 5.5 kg, with a mean of 3.20 ± 0.66 kg. Central catheters were placed in the femoral vein (FV) region in 71.6% of the babies (n = 144) and in the internal jugular vein region in 28.4% (n = 57). When culture results were examined between postoperative days 3 to 14, blood culture tests were positive in 12.4% (n = 25). The most common bacteria in positive cases were Klebsiella spp. (n = 13) and methicillin-resistant Staphylococcus aureus (n = 5). There was no statistically significant difference in blood culture results between the groups (P > .05). Changes in white blood cells, C-reactive protein, and procalcitonin measurements between preoperative and postoperative day 3 did not show statistically significant difference between the groups (P > .05). According to the results of our study, the placement of FV and internal jugular vein in neonates undergoing cardiac surgery did not differ in terms of postoperative infection risk. With appropriate sterilization, preventive measures and care considerations, FV or internal jugular vein region may be preferred based on the practitioner’s expertise and choice in this patient group.